1st Optimal HRT Alternatives: 10 Options in 2026 and What 120 Days Can Cost

Answer capsule: The best 1st Optimal HRT alternatives depend on why you are leaving: Midi Health for commercial PPO billing, Alloy for transparent cash-pay medication prices, Elektra Health for Medicare or Medicaid where available, and Winona for a bundled FDA-approved patch-and-progesterone route. First confirm whether 1st Optimal’s 120-day minimum applies to your account.

Affiliate disclosure: The HRT Index may earn a commission when a provider link is clearly marked as sponsored. That does not change who we include, who we exclude, or where an option appears. 1st Optimal pays us nothing. Under our current sitewide affiliate disclosure, Winona, Sesame, and Wisp may pay us; Midi Health, Alloy, Elektra Health, MyMenopauseRx, Gennev, Stella, and the local-clinician route do not.

1st Optimal lists Perimenopause Care at $129 a month and Menopause Care at $239 a month. Its current Terms of Service state that memberships must remain active for at least 120 days. That last sentence is the one most people miss. And it is why this page compares the first four months instead of pretending one monthly price tells the whole story.

Here is what makes the decision harder: 1st Optimal’s FAQ says membership is billed month-to-month with no long-term contract. Its Terms of Service say a minimum of 120 days. Its women’s membership page says membership lasts for the length of the prescribed treatment, using a 12-week protocol as an example. We show all three because a monthly price you cannot leave for 120 days is a different kind of number than one you can cancel on Tuesday.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

Quick clarification: this page is about 1st Optimal, the Michigan-based telehealth company at 1stoptimal.com. It is not about Optimal Workshop, and it is not a guide to non-hormonal treatment itself. If you want a different treatment approach rather than a different provider, jump to What about non-hormonal alternatives to HRT?.

Best for / Not for you if

Start with Midi Health if you have commercial PPO coverage, want the visit billed to insurance when your exact plan is in-network, want a prescription sent to your own pharmacy, or want to stop paying a recurring membership fee.

Start with Alloy if you are paying cash, already have a strong route preference, and want to see the medication price before you complete intake. Alloy charges a one-time $49 consultation fee and prices each medication separately.

Start with Elektra Health if you have Medicare or Medicaid and live in a state and plan network it serves. Elektra is the only provider in this ten-option roster whose official site explicitly publishes participation with both programs.

Start with Winona if you want an FDA-approved estradiol patch and FDA-approved progesterone capsules shipped within one recurring program, and you meet its age and state gates.

Do not switch yet if you have not asked 1st Optimal which plan you are in, what lab work is included in that plan, what medication will be invoiced separately, and which cancellation document governs your account. Any one of those answers can materially change your bill.

Do not start with online-only care if you have bleeding after menopause, new or unexplained pelvic pain, severe or sudden symptoms, or a history that requires examination or specialist coordination before treatment. We explain that line clearly in When online HRT care is not the right starting point.

---

Which 1st Optimal HRT alternatives fit your reason for leaving?

Answer capsule: There is no single winner for every reader. The right alternative changes with the problem you are solving: insurance billing, one-medication pricing, Medicare or Medicaid access, local vaginal treatment, live video care, or freedom from a recurring membership. The table below routes by decision—not by affiliate payout.

Your reason for leaving	Start with	Published price verified August 2026	What you give up	Verify before you pay
“I want my commercial insurance to count”	Midi Health	Plan-specific cost-sharing; $250 initial / $150 follow-up self-pay	Labs and medication are separate	Your exact plan and state—an insurer logo is not a coverage guarantee
“I am on Medicare or Medicaid”	Elektra Health	Plan-specific when covered; $249 initial / $149 follow-up cash	State and plan availability are narrower	Your state, specific plan, referral rules, and network status
“I only take one medication”	Alloy	$49 one-time consult, then the product price	No insurance billing; most products ship in multi-month quantities	The full card charge, not only the monthly equivalent
“I want a lower self-pay visit price”	MyMenopauseRx	$150 per visit	Labs and medication are separate	Your state, plan, visit cadence, and prescription cost
“I want an FDA-approved patch and progesterone shipped together”	Winona	$149 patch + $39 progesterone capsules per 28-day cycle	Age 35–59, state limits, asynchronous care	Age, state, exact finished products, and first processing date
“I want video care, named labs, and a local pharmacy”	Sesame	From $59/month; $49/month for eligible Costco members	Cash-pay visit model; medication is separate	Checkout total, term, lab rules, and pharmacy cost
“My main problem is vaginal dryness or painful sex”	Read the GSM section first	The right local treatment may cost less than a systemic program	You may not need a broad membership	Whether the provider can prescribe the exact local route you need
“I want comprehensive functional-medicine coaching and broad monitoring”	Possibly stay with 1st Optimal	$129 or $239/month, plus separately priced treatment where applicable	Cash-pay model and an unclear commitment conflict	Itemized first-120-day estimate and written cancellation date

One constraint sits on top of every row: if the 120-day minimum in 1st Optimal’s Terms applies to your account, finding your exit date is the first step of switching—not the last.

---

The right provider is not the same for every woman

Answer capsule: Provider fit changes with symptoms, uterus status, route preference, risk history, insurance, state, and whether the problem needs an examination. A price table cannot safely resolve all of that. Use the matching tool before you pay when you are unsure which lane applies to you.

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

→ Match my situation before I compare providers Get a personalized starting-point plan and see which details still need a clinician, benefits check, or state-specific confirmation.

---

Before you switch, is 1st Optimal actually the problem?

Answer capsule: Some reasons for leaving may be fixable without changing providers. 1st Optimal publishes two women’s plans at $129 and $239 a month, while the public pages do not clearly explain the assignment rule, the exact included lab panel, or the final medication price. Get those answers before paying to rebuild care elsewhere.

We earn nothing if you stay. We are telling you this anyway, because switching providers to solve a plan-assignment or itemization problem is a genuinely expensive mistake.

1. Which plan are you in?

1st Optimal’s women’s plans page lists:

• Perimenopause Care: $129 a month
• Menopause Care: $239 a month

That is a $110 monthly difference—$1,320 across twelve charges. The public plan page explains who each plan is “best for,” but it does not publish a clinical or commercial rule that lets a reader know in advance which plan she will be placed in, whether the plan can change after intake, or what happens to price if the company changes her life-stage classification.

Ask this: “Which plan am I being placed in, who makes that decision, and can my monthly price change after intake?”

2. Which labs are actually included?

The published pages create a narrower—but still important—question. 1st Optimal’s FAQ says membership includes lab testing, while its plan pages advertise ongoing blood work monitoring and review. The company also sells standalone panels separately in its shop. Those statements do not identify the exact panel, collection method, cadence, redraw policy, or specialty tests included in each plan.

The question is not simply “Are labs included?” It is:

“Which exact tests, collection method, and testing cadence are included in my plan—and which panels, redraws, or specialty tests would be billed separately?”

Get the answer in writing. A general promise of “lab testing” is not an itemized benefit.

3. Do you want the broader service 1st Optimal is selling?

If you want a functional-medicine model with coaching, messaging, ongoing monitoring, and access to treatments priced separately or at member rates, 1st Optimal is not selling the same product as a $49 consultation plus one prescription. A broad service can be worth more to the person who will use it.

Whether it is the right product for hot flashes, vaginal symptoms, or one stable prescription is a different question.

4. Ask for one number before you leave

Request a written estimate showing:

• membership charges through your earliest cancellation date;
• included and separately billed labs;
• exact medication, strength, route, quantity, and refill frequency;
• medication and shipping charge;
• when each charge will hit your card;
• refundability after the pharmacy begins work.

If that itemized number still does not fit, keep reading. The rest of this page is for you.

---

What can 1st Optimal cost over 120 days?

Answer capsule: At the published plan prices, four monthly charges equal $516 for Perimenopause Care or $956 for Menopause Care. Because the Terms require a membership-change request after the initial 120 days and at least seven days before the next billing cycle, a fifth charge may be possible depending on timing. Medication and any nonincluded testing remain separate.

Most comparison pages stop at the monthly price. That number is close to useless here, and we will show you why.

Three current 1st Optimal pages describe the commitment differently

1st Optimal document	What the published page says	What it means before you pay
FAQ	Membership is billed monthly and there is no long-term contract	Suggests a conventional month-to-month relationship
Terms of Service	Minimum 120 days; automatic renewal; change request after the initial 120 days; request at least seven days before the next billing cycle	Creates the most restrictive published cancellation rule
Women’s membership page	Membership runs for the length of the prescribed treatment; a 12-week protocol is used as the example	Connects duration to the prescribed protocol rather than a fixed month-to-month rule

Three answers to one question: what am I agreeing to?

We are not calling this deceptive, and you should not either. The pages may have been written or updated at different times. Documents drift. It happens at good companies.

But the Terms are part of the agreement presented to the customer, and you are the one whose card will be charged. The reader action is simple and costs nothing:

Ask in writing which cancellation rule and earliest exit date apply to your account before you pay.

The four-charge and five-charge scenarios

Plan	Four monthly charges	Five monthly charges
Perimenopause Care ($129/month)	$516	$645
Menopause Care ($239/month)	$956	$1,195

These are The HRT Index calculations, not provider quotes and not guaranteed totals. Four charges illustrate 120 days as four monthly billing cycles. Five charges show the possible cash-flow consequence if the post-120-day request and seven-day notice rule push cancellation past another renewal.

What those figures do not settle

They do not tell you:

• which lab tests are included;
• whether optional or specialty panels are extra;
• which prescription will be selected;
• whether the finished medication is FDA-approved or compounded;
• what medication, pharmacy, shipping, supplements, or supplies will cost;
• whether your protocol duration creates a different renewal timeline.

That is why we call $516 and $956 membership scenarios, not all-in treatment prices.

Two more billing conflicts worth resolving in writing

The Terms say membership is billed monthly on the same day as the initial signup. The FAQ says drafts run on the 1st or 16th, depending on the signup date. Those rules can create different renewal dates.

The refill timing also conflicts. The FAQ says invoices for labs, supplements, and prescriptions are processed approximately three weeks before the refill date for existing patients. The women’s membership page says treatment orders are processed on the card on file six to seven weeks before the refill date. That is roughly a month of difference on a charge that may become nonreturnable after processing starts.

Ask four separate questions:

1. “What is my exact membership renewal date?”
2. “Which published billing rule governs my account—the signup anniversary or the 1st/16th schedule?”
3. “On what date will my next treatment order be charged?”
4. “At what point does that order become nonrefundable?”

Get the dates in writing. Membership renewal and pharmacy processing are not the same event.

For a deeper breakdown, see our 1st Optimal cost guide and 1st Optimal insurance guide.

---

What do the alternatives cost over the same 120-day window?

Answer capsule: The providers use incompatible billing models: monthly membership, per visit, 28-day prescription cycle, three-month shipment, insurance claim, and local-pharmacy prescription. The table normalizes published prices to a 120-day decision window without pretending the packages are identical. Insurance, medication selection, dose, labs, and the number of follow-ups can still change the total.

Read this before the table: every amount below is tied to a current published price verified in August 2026. A “120-day scenario” is editorial arithmetic, not a treatment recommendation, eligibility decision, insurance quote, or promise that a clinician will choose that regimen.

An online HRT provider is not cheaper merely because its monthly number is lower. The honest comparison separates care, medication, labs, insurance, refill timing, and minimum commitment—and most pages do not.

Provider or route	Published charge	120-day comparison scenario	What the number includes	What remains variable
1st Optimal — Perimenopause Care	$129/month	$516 for four charges; $645 for five	Membership benefits described by the selected tier	Medication, exact included labs, optional testing, supplements, timing
1st Optimal — Menopause Care	$239/month	$956 for four charges; $1,195 for five	Membership benefits described by the selected tier	Medication, exact included labs, optional testing, supplements, timing
Midi — commercial insurance	Plan-specific copay, coinsurance, deductible	Cannot be responsibly estimated without the plan	Covered visit when in-network	Benefits, labs, medication, number of visits
Midi — self-pay	$250 initial; $150 follow-up	$400 if two visits occur	Two clinical visits	Labs, medication, pharmacy cost
Alloy — estradiol pill	$49 consult + from $39.99/month	$208.96 four-month equivalent	Clinician review, ongoing messaging while prescription is active, medication	Actual multi-month card charge, dose, added progesterone
Alloy — estradiol patch	$49 consult + $100/month, billed in three-month supplies	$449 four-month use equivalent; $349 initial charge, then about $300 at the next three-month refill if still active	Clinician review, messaging, shipped medication	Refill timing, added progesterone, clinical eligibility
Winona — patch + progesterone capsules	$188 per 28-day cycle	$940 in card charges on an uninterrupted 28-day schedule through day 112; $752 is four fills	Clinician review, messaging, shipping, both medications	Pauses, cancellation timing, eligibility, dose, other products
Sesame — standard women’s health subscription	From $59/month	$236 for four months	Ongoing care features and labs when included under current program rules	Exact checkout total, term, medication, state lab mechanics
Sesame — eligible Costco member rate	$49/month	$196 for four months	Discounted women’s health subscription	Costco eligibility, checkout terms, medication
Elektra Health — self-pay	$249 initial; $149 follow-up	$398 if two visits occur	Two clinical visits	Labs, medication, coaching outside coverage, state availability
Gennev — self-pay doctor visits	$250 initial; $199 follow-up	$449 if two visits occur	Two physician visits	Labs, medication, additional care
Stella — self-pay	$200 initial; $90 follow-up	$290 if two visits occur	Two clinical visits	Medication, labs, insurance reimbursement outcome
MyMenopauseRx — self-pay	$150 per visit	$150 for one visit; $300 for two	Clinical visit and care plan	Labs, medication, number of visits
Wisp menopause consult	$99	$99 covers consult, follow-ups, and three months of Care Team access	Three months of clinical access	Day 91–120 care, medication at local pharmacy, labs if ordered elsewhere
Local clinician + retail pharmacy	Visit and medication prices vary	Get an exact current quote	Depends on clinician and pharmacy	Dose, product, insurance, coupon, visit cadence

What the comparison reveals

1. 1st Optimal is the only option here with a published minimum-term conflict tied directly to a monthly membership.
2. Winona’s “monthly” price runs on a 28-day clock. That can create thirteen processing cycles in a year, not twelve.
3. Alloy’s monthly equivalents commonly arrive as a three-month card charge. A $100 monthly patch can mean roughly $300 posts at once, plus the one-time consultation fee.
4. Insurance-based care cannot be normalized to a fake average copay. Your deductible and coinsurance are not editorial details.
5. A $99 consult is not an all-in HRT cost. Wisp sends a prescription to a local pharmacy, where the medication costs extra.
6. A broad membership and one prescription are not the same product. The table is built to expose structure, not to pretend equivalence.

One thing this table cannot do is tell you which route actually matches your symptom. That is the next section, and it may matter more than every price above.

---

If your main symptom is vaginal dryness or painful sex, should you switch providers?

Answer capsule: Maybe—but first confirm that you are comparing the right treatment category. For genitourinary syndrome of menopause, current guidance includes regular moisturizers and lubricants for milder symptoms and prescription options such as low-dose vaginal estrogen, vaginal DHEA, or oral ospemifene when appropriate. A systemic membership is not automatically the right tool for a local symptom.

Let us start with credit, because it is earned.

1st Optimal’s published article on genitourinary syndrome of menopause names evidence-based local and nonestrogen options and cites clinical sources. That is a higher content standard than many telehealth sales pages meet. We want that on the record.

GSM—genitourinary syndrome of menopause—is the umbrella term for vaginal, vulvar, sexual, and urinary changes associated with menopause. Dryness, burning, pain with sex, urinary urgency, and recurrent urinary infections can sit in this category. Local vaginal therapy and systemic therapy are not interchangeable simply because both may contain estrogen.

Here is the actual publishing gap

1st Optimal’s menopause program page describes hormone delivery as cream, patch, pellet, or injection. Its GSM article names low-dose vaginal estrogen, vaginal DHEA, and ospemifene as prescription options. The program page does not specifically identify whether those three therapies are available through the service or what they cost.

The word cream could include more than one route, and a public route list is not a complete formulary. The defensible conclusion is narrower: current availability and pricing for those three therapies are not clearly published.

What we are not saying

We are not saying 1st Optimal will not prescribe vaginal estrogen. We could not establish the current formulary from a published service page, so we are publishing the answer as unknown rather than turning an absence of detail into a “no.”

Your script, word for word:

“Can your clinicians prescribe low-dose vaginal estrogen, vaginal DHEA, or ospemifene? Which exact finished product would I receive, is it FDA-approved or compounded, and what would it cost?”

That question costs you nothing and works whether you stay or leave.

Why this matters more than the monthly price

The Menopause Society’s hormone-therapy position statement recommends low-dose vaginal estrogen or other therapies such as vaginal DHEA or oral ospemifene for bothersome GSM symptoms not relieved by over-the-counter treatment when systemic hormone therapy is not otherwise indicated. That does not mean one product is right for every woman; it means a local-symptom reader should not let a broad systemic membership answer the question by default.

If vaginal dryness or painful sex is your main reason for seeking care, paying for a broad systemic program before confirming a local-treatment route is an expensive way to solve the wrong problem.

Verified local-treatment examples in this roster

• Alloy publicly lists an FDA-approved estradiol vaginal cream at $39.99 a month, shipped as one three-month tube billed at $119.97.
• Winona publicly lists a compounded vaginal estrogen cream from $89 a month. The finished medication is compounded and is not FDA-approved.
• Midi, Elektra, MyMenopauseRx, Stella, Gennev, Wisp, and Sesame use clinician prescribing models that may send prescriptions to outside pharmacies, but the exact product and eligibility still require clinical confirmation.
• 1st Optimal publishes the GSM treatment categories but does not clearly publish current program availability or price for each one.

Does this sound like your situation? Check whether Midi is in-network for your exact plan and state. Midi sends prescriptions to outside pharmacies, so the medication can be evaluated under your own pharmacy benefit. Confirm the exact product and coverage first. This is an editorial link under our current affiliate disclosure.

---

Is Midi Health a better 1st Optimal alternative if you want insurance?

Answer capsule: Midi is the clearest alternative for many readers with commercial PPO coverage because it bills eligible plans, has no membership fee, and sends prescriptions to outside pharmacies. Self-pay is $250 for the first visit and $150 for follow-ups. Copays, deductibles, coinsurance, labs, and medication remain plan-specific and should not be reduced to one “average” number.

This is the single biggest structural difference between Midi and 1st Optimal.

1st Optimal is a cash-pay membership. Its own FAQ describes monthly billing and accepts HSA or FSA funds, but using an HSA or FSA is not the same as the provider submitting an insurance claim.

Midi bills commercial insurance when the exact plan is in-network. Its pricing page says it is in-network with most PPO plans and tells readers to check by state and carrier. It also publishes self-pay prices of $250 for an initial visit and $150 for a returning visit.

Why we do not publish an average insured visit price

Midi’s current pricing page says costs vary by plan, deductible, coinsurance, and copay. An insured visit may be inexpensive for one member and subject to a deductible for another. The comparison therefore shows insured cost as plan-specific rather than manufacturing an average that cannot be verified for the reader’s plan.

What Midi is and is not

Best for:

• commercial PPO members whose exact plan is in-network;
• readers who want menopause-focused care without a recurring membership;
• readers who want the prescription sent to an outside pharmacy;
• readers who want visit and medication coverage evaluated separately.

Not for you if:

• you are enrolled in Medicaid or Medi-Cal—Midi states it cannot treat those patients, even as self-pay;
• you need Midi itself to be covered by Medicare—Midi is out of network with Medicare, though its current pricing page says Medicare beneficiaries may be seen as self-pay and may not submit Midi-related claims;
• you want one flat, all-in number covering care, labs, and medication;
• your plan is an HMO or otherwise outside Midi’s contracted network.

The question that prevents the billing surprise

A carrier logo does not confirm your exact product, employer group, network, referral rules, deductible status, or telehealth benefit.

Ask your plan:

“Is this specific Midi clinical entity and clinician in-network for my plan, what will the initial and follow-up telehealth visits cost, and are the prescribed lab and pharmacy benefits separate?”

Then save the reference number or written response.

→ Check whether Midi is in-network with your exact plan. Confirm the plan—not only the carrier—before booking. This is an editorial link under our current affiliate disclosure.

---

What is the honest problem with our own top recommendation?

Answer capsule: Midi’s $250 self-pay first visit is more expensive than several pay-per-visit competitors, and that price does not include medication or labs. Insurance eligibility is not a guarantee of payment, Medicaid patients cannot use Midi even as self-pay, and Medicare beneficiaries must use the self-pay path. Those limits disqualify real readers.

We recommend Midi first for many commercial-insurance readers, and we give it the strongest commercial-insurance placement on this page. So here is the case against it, plainly.

Midi’s cash front door is expensive in the pay-per-visit lane. The $250 initial visit is higher than Stella’s $200, MyMenopauseRx’s $150, and Wisp’s $99 three-month consult package. It is also only the visit. Medication and labs are separate.

Coverage can still go wrong. A plan may show the company as participating while applying a deductible, excluding a particular clinical entity, requiring a referral, or processing the claim differently than expected. That is why a generalized copay number does not belong in this comparison.

If you are on Medicaid or Medi-Cal, Midi is a dead end. Elektra may be the relevant virtual path where your state and plan are supported. MyMenopauseRx or another local covered clinician may be better for some commercial plans.

If one predictable cash number matters more than insurance billing, 1st Optimal’s bundle may feel simpler. A membership can be easier to budget than separate claims, prescriptions, labs, and follow-ups—even when the membership costs more.

But here is why Midi still wins the commercial-PPO lane for the right reader. It separates the clinical visit from the prescription, does not require a recurring membership, and sends the medication to an outside pharmacy. If a subscription made you feel stuck, the fix is not a cheaper subscription. It is not having one.

---

Which alternative works with Medicare or Medicaid?

Answer capsule: Elektra Health is the only provider in this ten-option roster whose official site explicitly publishes participation with both Medicare and Medicaid. Coverage is not universal: it depends on state, exact plan, network, and sometimes referral rules. Where Elektra is unavailable, a local covered clinician is the realistic path—not a cash-pay affiliate substitute.

This is the shortest section on the page and the most important one for the reader it applies to.

The current roster

• 1st Optimal: cash-pay; no broad published Medicare or Medicaid participation statement.
• Midi: out of network with Medicare; Medicare beneficiaries may use self-pay under its current page but cannot submit related claims; Medicaid and Medi-Cal patients cannot be treated even as self-pay.
• Sesame: cash-pay and does not accept third-party insurance. Its Terms require users to certify they are not Medicare, Medicaid, or TRICARE beneficiaries.
• Winona, Alloy, and Wisp: cash-pay care or medication models; they do not bill Medicare or Medicaid for the telehealth service.
• Gennev: commercial-insurance or self-pay; federal-program participation is not established on the current pricing page.
• Stella: its marketing pages describe in-network care, while its Terms say Vira Health does not accept commercial insurance and is not enrolled in Medicare or Medicaid. Verify the governing rule before booking.
• MyMenopauseRx: does not accept Medicare, Medicaid, or HMO plans.
• Elektra Health: states that it became the first virtual menopause provider to accept Medicare and Medicaid and publishes plan-specific government coverage.

Elektra pays us nothing. No commission. No affiliate incentive. It is here because it is the documented answer in this roster.

The catch is not small

Elektra’s insurance participation is plan- and state-specific. Its FAQ shows different accepted networks in different states and a current cash price of $249 for the first visit and $149 for follow-ups. It also says labs and medications may still run through their own benefits.

Do not book from the words “accepts Medicare and Medicaid” alone. Confirm:

• the legal clinical entity;
• your exact plan and product;
• the clinician’s network status;
• state availability;
• referral requirements;
• lab and pharmacy coverage;
• whether a plan’s network status is scheduled to change.

If Elektra is not available under your plan, the honest next step is a local clinician who participates in your coverage. We would rather give you the unmonetized answer than force a cash-pay provider into a problem it does not solve.

---

Is Alloy a better cash-pay alternative?

Answer capsule: Alloy is a strong cash-pay alternative for readers who want FDA-approved menopause medications priced product by product rather than a recurring care membership. It charges a one-time $49 consultation fee, includes ongoing doctor messaging while the prescription remains active, and commonly ships and bills three months of medication at a time. It does not bill insurance.

Alloy is the structural opposite of a broad membership. You pay for clinician review once, then pay for the drug you actually use.

For a woman on one stable medication, that arithmetic is hard to ignore.

Current published medication prices

Alloy option	Published monthly equivalent	How it is charged	Four-month equivalent including $49 consult
Estradiol pill	From $39.99	Product page or catalog; multi-month fulfillment may apply	$208.96
Estradiol patch	$100	Shipped and billed every three months	$449
Estradiol gel	$69.99	Three-month supply	$328.96
Evamist estradiol spray	$69.99	Three-month supply	$328.96
Progesterone	From $23	Added when prescribed	$141 minimum if used alone
Paroxetine	$34.99	Nonhormonal hot-flash option	$188.96
Estradiol vaginal cream	$39.99	One three-month tube billed at $119.97	Package price should be shown first

These are catalog equivalents, not a promise that the clinician will prescribe a specific product or that one-product therapy is appropriate. A person with an intact uterus using systemic estrogen generally needs an endometrial-protection plan, so a cheap estrogen-only headline can understate the real regimen.

The billing detail that changes the decision

Alloy’s patch page says $100 per month, but it also says the patch is shipped and billed every three months. That means the useful number is not only $100. It is roughly $300 posting at once, plus the one-time $49 consultation fee.

The same principle applies across the catalog: ask what the card charge will be today, not only what the company calls the monthly equivalent.

Best for / Not for you if

Best for:

• cash-pay readers;
• one or two clearly priced medications;
• FDA-approved manufactured menopause products;
• no recurring clinical membership;
• asynchronous care and shipped medication.

Not for you if:

• you need the visit billed to insurance;
• you want a local pharmacy;
• you need month-by-month card charges rather than multi-month fulfillment;
• you want broad functional testing, health coaching, or testosterone;
• you are unsure whether your symptom needs local or systemic treatment.

Alloy pays us nothing. It is here because the single-medication evidence puts it here.

---

Is Winona a better bundled alternative?

Answer capsule: Winona includes clinician review, messaging, shipping, and medication in the product subscription. Its current catalog lists an FDA-approved estradiol patch at $149 and FDA-approved progesterone capsules at $39. Its FAQ says 30-day supplies are processed every 28 days. Eligibility is generally limited to ages 35–59 and the states Winona serves.

If you liked 1st Optimal’s bundled shape but not its price or functional-medicine workup, Winona is the closest match in structure.

The 28-day billing detail nobody should hide

Winona’s FAQ says a 30-day prescription is processed every 28 days and a 90-day prescription every 84 days. That is not a calendar-month cycle.

For patch plus progesterone:

• one 28-day cycle: $188;
• four cycles: $752;
• five charges: $940.

On an uninterrupted schedule beginning with the first paid prescription, charges can post on days 0, 28, 56, 84, and 112. That is five $188 charges, or $940, within 120 days. Four fills total $752, but four fills are not the same as first-120-day card activity when the fifth refill processes on day 112. A pause or timely cancellation can change that cash flow.

Across a full year, a strict 28-day cadence can produce about thirteen processing cycles. Ask for the next twelve charge dates in the portal before you compare it with a calendar-month membership.

Where Winona genuinely wins

Winona’s public catalog distinguishes its categories at the product level:

• Estradiol patch: presented as an FDA-approved manufactured product.
• Progesterone capsules: presented as FDA-approved.
• Estrogen body creams, combined body creams, progesterone creams, and vaginal estrogen cream: explicitly presented as compounded in the USA.

That product-level separation is useful. The finished compounded creams are not FDA-approved, even when a page says an ingredient is used in approved drugs or meets a pharmacopeial standard.

One current Winona FAQ answer conflicts with that product-level labeling. It broadly says all Winona HRT options are compounded, while the current catalog labels the estradiol patch and progesterone capsules as FDA-approved and the creams as compounded. Do not resolve that conflict from the brand name alone. Ask for the exact finished product, manufacturer or labeler, dispensing pharmacy, and current FDA-approved labeling before approving the prescription.

The gates that disqualify readers

Age: Winona’s FAQ says most women ages 35–59 with menopause symptoms are generally eligible, subject to clinician review. If you fall outside that band, do not complete an intake assuming an exception.

State: Winona currently serves Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, Washington, Wisconsin, Wyoming, and Puerto Rico. Confirm again before paying because telehealth licensure can change.

Visit format: Winona is primarily asynchronous. If you want live video or phone care, another provider is a better fit.

Cancellation and pharmacy timing: Winona’s current policy gives a short review window before pharmacy processing. Once a patient-specific prescription enters processing, refunds can be restricted. Cancel before the next pharmacy step, not after the package ships.

The compounded-cream issue that cannot be solved with copy

If you have an intact uterus and are considering a compounded combined body cream as your only systemic estrogen-and-progesterone regimen, ask exactly how the clinician is providing and monitoring endometrial protection. Do not assume that progesterone applied through skin provides the same evidence or absorption as an FDA-approved oral product.

If the FDA-approved patch and progesterone-capsule route fits what you are looking for, check Winona’s current age and state eligibility first. Confirm the exact finished products and next charge date before approving the prescription. We may earn a commission if you use this link.

---

Is Sesame a cheaper alternative?

Answer capsule: Sesame currently publishes a women’s health subscription from $59 a month, while eligible Costco members can access a $49 monthly women’s health rate. Four published monthly charges equal $236 or $196. Medication is separate, and checkout still needs to confirm the term, first charge, lab rules, provider availability, and pharmacy cost.

Sesame’s current women’s health page publishes ongoing menopause and PCOS care from $59 a month. Its Costco-member page publishes $49 a month for the women’s health subscription. Those are current provider-stated prices, not third-party estimates.

What Sesame includes publicly

The current women’s health page highlights:

• ongoing care for menopause or PCOS;
• same-day access to prescriptions and refills where clinically appropriate;
• included labs under the program’s current rules;
• treatment adjustments;
• in-app prescription tracking.

The platform also uses video care and provider messaging. Prescriptions can be sent to a pharmacy, and medication price is not the same as the subscription price.

What to verify before booking

• whether the displayed price is $59, $49 through Costco, or another live checkout rate;
• the minimum subscription term and renewal date;
• which labs are included, who orders them, and where they are performed in your state;
• whether the provider is licensed and available in your state;
• medication price and pharmacy coverage;
• refund and cancellation timing;
• whether the requested medication is controlled;
• whether you are eligible under Sesame’s Terms, which say Sesame does not accept Medicare, Medicaid, or other third-party insurance and require users to certify they are not Medicare, Medicaid, or TRICARE beneficiaries.

Sesame’s published prescription guidance says online providers on the platform do not prescribe controlled substances. That means this is not a testosterone route.

Best for / Not for you if

Best for: you want live care, a lower published subscription price, program labs, adjustments, and a prescription sent outside the membership.

Not for you if: you need the visit billed to insurance, are a Medicare, Medicaid, or TRICARE beneficiary under Sesame’s current Terms, require testosterone, or need a guaranteed all-in number that includes the medication before clinical review.

→ See Sesame’s live menopause price and the lab rules for your state. Use the current checkout total—not an old comparison-page number—as the final commercial fact. We may earn a commission if you use this link.

---

What about Elektra, MyMenopauseRx, Gennev, Stella, Wisp, or a local clinician?

Answer capsule: The remaining alternatives are not filler. Elektra is the federal-insurance lane; MyMenopauseRx offers a lower $150 self-pay visit and commercial insurance; Gennev and Stella provide live specialist care; Wisp offers three months of access for $99; and a local clinician may be the simplest way to use an existing network and pharmacy benefit.

Elektra Health

Punchline: best documented virtual option in this roster for Medicare or Medicaid where the exact plan and state are supported.

• $249 initial and $149 follow-up cash price.
• Commercial and government-plan participation published.
• FDA-approved hormonal and nonhormonal medications only, according to its FAQ.
• Labs and prescriptions as clinically needed.
• Clinical care is currently licensed in 16 states: New York, Connecticut, Massachusetts, Florida, Pennsylvania, New Jersey, Illinois, Arizona, Georgia, Iowa, Missouri, Nebraska, Ohio, Oklahoma, Tennessee, and Texas. Networks vary within that footprint.

Choose it when: federal-program coverage is the reason you are switching.

Do not choose it from the word “covered” alone: verify your exact plan, referral requirement, and clinician network.

MyMenopauseRx

Punchline: lower published self-pay visit price than Midi, Gennev, Stella, or Elektra, with commercial-insurance billing and prescriptions sent to a pharmacy of your choice.

• $150 per self-pay virtual visit.
• Major commercial insurer logos published, with actual cost dependent on the plan.
• Discounted self-pay lab options and Quest-based testing.
• FDA-approved estradiol and progesterone published in its FAQ.
• It does not accept Medicare, Medicaid, or HMO plans.
• Testosterone is treated as a controlled-substance pathway: direct prescribing is published for patients located in Illinois, with coordination through a local primary-care clinician elsewhere.

Choose it when: you want insurance or a $150 self-pay visit and prefer a local pharmacy.

Watch the cancellation rule: its Terms require advance notice for refunds, and payment for completed clinical evaluation is not refunded merely because a requested prescription is not medically appropriate.

Gennev

Punchline: live menopause-focused physician care with commercial-insurance and self-pay options.

• $250 initial physician visit.
• $199 physician follow-up.
• Separate registered-dietitian visits at published prices.
• Medication and labs are separate.

Choose it when: you want live physician care and a broader lifestyle pathway without a monthly membership.

Stella

Punchline: straightforward self-pay video pricing, but its insurance pages and Terms currently conflict.

• $200 initial visit.
• $90 follow-up.
• Current marketing pages describe in-network care and a superbill path for out-of-network reimbursement.
• Stella’s Terms say Vira Health does not accept commercial insurance and is not enrolled in Medicare or Medicaid.
• Medication and lab costs are separate.

Choose it when: predictable visit pricing and live menopause care matter more than a shipped bundle. Do not rely on the word “in-network” until Stella confirms your exact plan and which document governs billing in writing.

Wisp

Punchline: the lowest published front-door care price in this roster, but it covers only three months of care access and not the medication.

• $99 includes the consultation, follow-ups, and three months of Care Team access.
• If prescribed, medication goes to a local pharmacy and costs extra.
• Estradiol patch, gel, oral options, and progesterone options are listed.
• Available in all 50 states according to the current product page.

Choose it when: you want a low-cost consult and local-pharmacy prescription rather than an ongoing membership.

Do not call it a $99 four-month treatment: the published access period is three months, so day 91 through day 120 needs confirmation.

Your own clinician and retail pharmacy

This route deserves a place in the comparison because it can solve what the affiliate market cannot:

• use your existing insurance network;
• coordinate pelvic exams, imaging, and preventive care;
• send a manufactured prescription to any participating pharmacy;
• avoid a second telehealth relationship;
• maintain one record across conditions.

We do not publish a universal generic-medication floor. Retail cash, coupon, dose, quantity, product, and insurance prices move too often to turn one snapshot into a durable answer. Get the exact prescription first, then compare your plan price, pharmacy cash price, manufacturer program, and legitimate discount price on the same day.

---

Which alternatives can actually bill insurance?

Answer capsule: Insurance billing, HSA or FSA payment, a superbill, and pharmacy coverage are four different things. Midi, MyMenopauseRx, Gennev, Stella, and Elektra publish insurance or reimbursement pathways, but every network is plan-specific. 1st Optimal’s acceptance of HSA or FSA funds does not mean it bills your health plan.

This distinction costs women real money because four different questions get collapsed into “Do you take insurance?”

1. Direct insurance billing: the clinical provider submits a claim.
2. HSA or FSA payment: you use your own tax-advantaged funds. This is not insurance billing and does not by itself satisfy a deductible.
3. Superbill reimbursement: you pay cash and submit documentation to your plan, which may reimburse nothing, part, or all.
4. Pharmacy benefit: the prescription is a separate claim from the visit.

Current insurance lanes

Provider	Direct clinical insurance billing	Self-pay price	Medicare / Medicaid	Medication path
Midi Health	Most PPO plans; exact plan and state required	$250 / $150	Medicare out of network; Medicaid and Medi-Cal not accepted	Outside pharmacy
Elektra Health	Commercial and selected government plans	$249 / $149	Both published, plan- and state-specific	Preferred pharmacy
MyMenopauseRx	Seven named commercial plan families	$150 per visit	Medicare, Medicaid, and HMO plans not accepted	Pharmacy of choice
Gennev	Commercial coverage varies by plan	$250 / $199	Confirm exact plan	Outside pharmacy
Stella	Marketing pages describe in-network care; Terms say Vira Health does not accept commercial insurance; superbill also published	$200 / $90	Terms say no Medicare or Medicaid; verify the governing billing rule	Outside pharmacy
1st Optimal	Cash-pay membership	$129 or $239/month	No broad participation statement	Affiliated and other pharmacy arrangements; exact product must be confirmed
Alloy, Winona, Wisp	Cash-pay service model for this comparison	Published cash price	Not billed as a federal-program visit	Shipped or local-pharmacy medication, depending on provider
Sesame	Cash-pay; does not accept third-party insurance	From $59/month	Terms require users to certify they are not Medicare, Medicaid, or TRICARE beneficiaries	Outside pharmacy

The sentence this table exists to deliver

If you are leaving 1st Optimal because insurance should count, do not replace it with another cash-pay homepage before checking the five providers that publish an insurance or reimbursement lane.

And do not let “HSA/FSA accepted” answer the wrong question. Ask: “Will you submit a claim to my exact plan?”

---

What is the difference between FDA-approved and compounded hormone therapy?

Answer capsule: A compounded drug is prepared for an individual patient and is not FDA-approved. FDA does not review a compounded product for safety, effectiveness, or quality before marketing. FDA-approved products have gone through an approval process for the exact finished drug. Compounding can meet patient-specific needs, but the categories are not interchangeable.

This is where the most expensive confusion in menopause care lives.

Two sentences worth memorizing

“Bioidentical” describes a hormone’s relationship to a human hormone; it does not tell you whether the finished drug is FDA-approved or compounded. FDA-approved estradiol products and oral micronized progesterone can be described as bioidentical.

FDA approval applies to a specific finished drug product—not to a telehealth brand, pharmacy, ingredient, or provider. There is no such thing as an “FDA-approved provider.”

Why an NDC number does not prove FDA approval

An NDC is an identifier—not an approval certificate.

FDA states that assignment of an NDC number does not denote FDA approval, and using an NDC to create that impression is misleading. The NDC Directory can include listed products that are not approved, including compounded products.

Use this verification sequence instead:

1. Ask for the exact finished product name, strength, route, manufacturer or labeler, and dispensing pharmacy.
2. Ask directly: “Is this finished prescription FDA-approved or compounded?”
3. For a manufactured product, verify the exact drug in Drugs@FDA or the current FDA-approved labeling.
4. Use the NDC only as an identifier that may help match the package—not as proof of approval.

Where each provider sits

Provider	FDA-approved manufactured menopause products	Compounded products	What the reader must verify
1st Optimal	Not clearly mapped product by product on its public menopause program page	Public program and Terms identify compounded pathways and a 503A affiliated pharmacy	Exact finished product and regulatory category before payment
Midi Health	Main menopause prescribing includes FDA-approved options	Separately identified custom-prescription pathways may be available	Exact product, pharmacy, and state eligibility
Alloy	FDA-approved pills, patches, gel, spray, and vaginal estradiol product published	Compounded skincare products exist outside the core menopause-drug comparison	Do not transfer a skincare category to the HRT product
Winona	FDA-approved estradiol patch, estrogen tablets, and progesterone capsules published	Body creams and vaginal estrogen cream are labeled compounded	Exact finished product—not the status of an ingredient
Elektra Health	FAQ says it prescribes FDA-approved hormonal and nonhormonal medications	No compounded menopause line published	Exact prescription and pharmacy benefit
MyMenopauseRx	FDA-approved estradiol and progesterone published	No routine compounded menopause line identified on the public pages reviewed	Exact product sent to pharmacy
Gennev, Stella, Wisp, Sesame	Manufactured products may be prescribed through outside pharmacies	Do not assume none; confirm any custom product	Exact finished product and pharmacy

What ACOG and FDA say

FDA states that compounded drugs are not FDA-approved and that the agency does not verify their safety, effectiveness, or quality before marketing. FDA also recognizes that compounding can serve an important patient need when an approved product is not medically appropriate—for example, a needed dosage form or an allergy to an ingredient.

ACOG’s 2023 Clinical Consensus states that compounded bioidentical menopausal hormone therapy should not be prescribed routinely when FDA-approved formulations exist and that evidence supporting marketing claims of superior safety or effectiveness is lacking.

That is not a claim that every compounded prescription is illegitimate. It is the reason this page refuses to blur the categories or let “bioidentical” do regulatory work it cannot do.

Pellets deserve their own question

1st Optimal publishes pellets among its available hormone-delivery routes. A pellet is inserted and cannot be quickly removed once implanted. ACOG’s consensus highlights the lack of high-quality safety and pharmacokinetic data for compounded pellet therapy and advises considering other preparations.

Before accepting a pellet, ask:

• why a removable route is not the better first step;
• the exact hormone and dose;
• how adverse effects will be managed while the pellet remains active;
• which evidence supports the selected product;
• the full insertion and follow-up cost.

If you have an intact uterus

If you have an intact uterus and use systemic estrogen, your regimen generally needs endometrial protection—commonly a progestogen or another FDA-approved protective regimen. Low-dose local vaginal estrogen is a different clinical category and should not be treated as interchangeable with systemic estrogen.

Do not assume that progesterone in a compounded transdermal cream provides the same protection as an FDA-approved oral or otherwise established regimen. Ask:

“I have a uterus. What exact part of this regimen protects my endometrium, what evidence supports that route and dose, and how will you monitor me?”

Credit where it is due

1st Optimal names Belmar Pharmacy – Colorado as an affiliated 503A pharmacy in its Terms. Naming the pharmacy is a real transparency credit. It lets a patient verify the pharmacy, ask who compounds the finished prescription, and understand that a compounded product is regulated differently from an FDA-approved manufactured drug.

The credit and the limitation belong in the same section.

---

What if testosterone is the reason you want to switch?

Answer capsule: No testosterone product is FDA-approved specifically for women in the United States. Testosterone is a Schedule III controlled substance and requires a prescription from a licensed clinician following federal and state rules. A clinician may consider an FDA-approved male product off-label at female dosing or a compounded product; those routes are not regulatory equivalents.

Women are not limited to compounded testosterone. The regulatory categories need to stay separate.

What the evidence actually supports

The Menopause Society identifies testosterone as an evidence-based option for hypoactive sexual desire disorder in postmenopausal women after appropriate assessment. It is not a general-purpose treatment for weight loss, energy, brain fog, “optimization,” or anti-aging merely because a lab value is low.

No testosterone product currently has a U.S. FDA indication specifically for women. Off-label prescribing is legal when a licensed clinician uses an approved product for a nonapproved patient population or indication based on medical judgment. Compounded testosterone remains a separate, non-FDA-approved finished product.

What the roster publishes

• 1st Optimal: publishes testosterone within its women’s plan and describes compounded cream, injection, and pellet pathways. Confirm the exact product, dose, pharmacy, price, and state eligibility.
• Midi Health: publishes a compounded women’s testosterone pathway in 25 listed jurisdictions, including Washington, DC: AZ, CA, CO, DC, DE, FL, IA, IL, IN, KS, MA, MD, ME, NC, NJ, NM, NV, NY, OH, OR, PA, TX, UT, VA, and WA. Because testosterone is Schedule III, Midi says new visits are required for renewal.
• MyMenopauseRx: says it can prescribe testosterone directly for patients located in Illinois and coordinate with a local primary-care clinician in other states. Its FAQ expressly identifies testosterone as controlled.
• Elektra Health: says some clinicians can prescribe testosterone to patients residing in New York. Confirm the exact product and regulatory category; Elektra separately says it does not prescribe compounded or non-FDA-approved medications.
• Sesame: states that online providers on its platform do not prescribe controlled substances.
• Winona: says it does not offer testosterone.
• Alloy, Wisp, Gennev, and Stella: no broad women’s testosterone pathway was identified on the public menopause pages reviewed for this comparison.

The honest conclusion

If testosterone is the reason you are leaving, the first filter is not price. It is:

1. a clinically appropriate indication;
2. state and controlled-substance eligibility;
3. exact finished product and regulatory category;
4. monitoring and refill rules;
5. the prescriber’s plan if adverse androgenic effects occur.

Any page that describes testosterone as a frictionless add-on is minimizing a Schedule III prescription requirement. This one will not.

---

How should you judge the medical claims on a provider’s website?

Answer capsule: Use provider pages for commercial facts and as a record of what the company says—not as the final authority on efficacy, safety, or regulatory status. Verify the exact drug through FDA sources, compare clinical claims with guidelines or peer-reviewed literature, and read the Terms separately from the sales page.

1st Optimal deserves credit for publishing a referenced GSM article and for naming its affiliated pharmacy. It also publishes promotional pages that make broad claims about “optimization,” symptoms, routes, and expected results. The same is true across this industry.

The rule is simple:

• A product page can prove what the provider promises.
• A Terms page can prove the commercial rule you may be accepting.
• A pharmacy page can identify who may prepare the prescription.
• FDA sources establish whether the exact finished manufactured drug is approved.
• Clinical guidelines and peer-reviewed literature support medical claims.
• A testimonial proves only that a person or company published that testimonial.

The reader action

Before relying on a provider’s educational article, scroll to its references. Then ask whether the claim is about:

• an approved indication;
• an off-label clinical use;
• a compounded product;
• an editorial interpretation;
• or a marketing promise.

Those are five different things.

The same standard applied to us

This page is written and published by The HRT Index Editorial Team. No clinician reviewed it, so no clinician’s name is attached to it. We did not enroll, receive care, purchase medication, or test cancellation. We verified published prices, Terms, FAQs, treatment pages, and primary medical sources and dated the work.

That limitation does not disappear because the article is long. It is why every commercial fact still needs a final checkout or benefits confirmation before you pay.

---

What do customer reviews tell you about 1st Optimal?

Answer capsule: 1st Optimal has a much smaller independent review footprint than larger national platforms, so its star average is less stable and carries less evidence about recurring billing, fulfillment, and long-term care. Company testimonials can show how the service wants to be understood, but they cannot establish medical effectiveness or typical results.

The size of the pool is the finding.

A star rating without the platform, review count, and verification date is not a complete fact. A small pool can move dramatically after one new review. For that reason, this page does not freeze a dynamic score into the article or average unrelated platforms together.

What reviews can legitimately help with

Use attributable, independent reviews to look for patterns in:

• responsiveness;
• scheduling;
• billing clarity;
• pharmacy delays;
• ease of cancellation;
• clinician communication;
• record access;
• refill timing.

What reviews cannot establish

A review cannot prove that a hormone regimen is safe or effective for you. Company-published outcomes, weight-loss numbers, “reversed” conditions, and before-and-after claims are not clinical evidence and are not used to support this comparison.

The practical conclusion is not “1st Optimal is bad.” It is: a reader considering a $956 membership scenario has less independent process evidence to inspect than she would with a more mature review pool. That should increase the value of written itemization—not create a fake verdict from a handful of stars.

---

How do you leave 1st Optimal without losing money or a month of treatment?

Answer capsule: Confirm the governing cancellation rule and earliest exit date first, export records second, document the exact prescription third, and secure replacement care before cancelling. 1st Optimal’s Terms require a membership-change request after the initial 120 days and at least seven days before the next billing cycle, while its FAQ describes month-to-month billing.

Do these in order. The order is the whole point.

1. Find your exit date first

Ask which governs your account:

• FAQ month-to-month language;
• Terms’ 120-day minimum;
• protocol-length language on the membership page;
• any signed or checkout-specific document presented during enrollment.

Get the answer and the exact date in writing. Everything below depends on it.

2. Separate membership cancellation from pharmacy cancellation

Ask when the next membership charge posts and when the next prescription becomes nonrefundable. A provider can stop future care while a patient-specific pharmacy order is already in process.

3. Export your records before filing the change request

Download:

• lab results and reference ranges;
• visit notes;
• diagnosis list;
• current medication list;
• exact prescription labels;
• dosing instructions;
• adverse-effect history;
• pharmacy details;
• refill dates;
• prior authorization or superbill documents.

Do not buy the same information twice because you cancelled first.

4. Get the exact dose and finished product in writing

A new prescriber may not continue a compounded formula, pellet plan, or unclear dose. That is not obstruction. It is a clinician deciding whether she can safely assume responsibility for a product she did not select and may not be able to verify through standard labeling.

Switching is a continuity-of-care task, not merely a cancellation task.

5. Book replacement care before cancelling

Ask the new provider how long it expects intake, record review, lab review, prescribing, pharmacy processing, and shipping to take. Do not create a treatment gap by cancelling first and solving continuity later.

6. File the membership-change request and save proof

Save:

• the submitted form;
• confirmation email;
• effective date;
• final charge date;
• cancellation number;
• pharmacy cancellation response.

The billing-clock trap

Two prices that look identical often repeat on different clocks:

• Winona: every 28 days for 30-day prescriptions;
• Alloy: multi-month shipment and charge;
• 1st Optimal: monthly membership plus a separate treatment-processing timeline;
• pay-per-visit providers: charge only when a visit occurs;
• insurance providers: claim and pharmacy benefit settle independently.

Before comparing two numbers, find out how often each one repeats and how much actually hits the card.

---

What should you ask before paying any online HRT provider?

Answer capsule: Twelve questions expose the facts that determine real cost, continuity, and regulatory category. Ask for the exact card charge, commitment, included labs, finished drug, pharmacy, FDA-approved-versus-compounded status, insurance mechanics, local-treatment availability, refill timing, state eligibility, and cancellation date before you accept a plan.

Copy this. Print it. Paste it into a message. It works whether you stay or leave.

1. What exact amount will my card be charged today?
2. What is the minimum commitment, and what is the earliest date I can cancel without another charge?
3. Is the care fee separate from medication, labs, shipping, supplies, or supplements? Give me each price.
4. Which exact labs are included, which are optional, and how often are they repeated?
5. What exact finished product, strength, route, manufacturer or labeler, quantity, and pharmacy will I receive?
6. Is the finished prescription FDA-approved or compounded? If manufactured, where can I verify the exact product in Drugs@FDA?
7. If compounded, what patient-specific need does it address, and is it prepared under a 503A pharmacy or 503B outsourcing-facility pathway?
8. Do you bill my insurance, provide a superbill, or only accept HSA/FSA payment? What codes and clinical entity appear on the claim?
9. Can you prescribe low-dose vaginal estrogen, vaginal DHEA, or ospemifene if my main symptoms are vaginal or urinary?
10. Which plan am I being placed in, who decides that, and can the price change after intake?
11. How far before my refill will my card be charged, and when does the prescription become nonrefundable?
12. Are the clinician and pharmacy able to serve my state, and what happens if I move?

Still unsure which answers matter most for your situation? Use Find My HRT Path to build your starting-point question list.

---

What about non-hormonal alternatives to HRT?

Answer capsule: Nonhormonal treatment depends on the symptom. FDA-approved prescription options for moderate-to-severe hot flashes now include paroxetine mesylate, fezolinetant, and elinzanetant. Other evidence-based options may be used off-label. Vaginal moisturizers and lubricants remain first-line nonprescription tools for milder genitourinary symptoms.

Some readers searching for “1st Optimal alternatives” do not want a different company. They want a different treatment approach.

FDA-approved nonhormonal prescription options for hot flashes

• Paroxetine mesylate (Brisdelle): an SSRI formulation approved for moderate-to-severe vasomotor symptoms associated with menopause.
• Fezolinetant (Veozah): a neurokinin-3 receptor antagonist approved for moderate-to-severe vasomotor symptoms. FDA added a boxed warning about rare but serious liver injury and requires liver testing under the current label.
• Elinzanetant (Lynkuet): a neurokinin-1 and neurokinin-3 receptor antagonist approved in 2025 for moderate-to-severe vasomotor symptoms due to menopause. Its current label includes baseline liver testing and drug-interaction precautions.

A prescription being nonhormonal does not make it risk-free or automatically appropriate. The exact contraindications, interactions, and monitoring come from the current label and your clinical history.

Other prescription approaches

Clinicians may use medications such as certain SSRIs or SNRIs, gabapentin, or oxybutynin off-label for vasomotor symptoms. Off-label means an approved medication is prescribed for a use outside its FDA-approved labeling based on medical judgment and evidence. It does not mean “unregulated,” and it does not remove the need for a prescription.

Behavioral treatment

Cognitive behavioral therapy has evidence for reducing the distress and interference associated with hot flashes and for menopause-related sleep difficulties. It is not the same as claiming the therapy eliminates the underlying vasomotor event.

Supplements

Black cohosh, red clover, evening primrose, ginseng, and other supplements are sold under dietary-supplement rules rather than the drug-approval pathway. Product strength and quality can vary, evidence is mixed, and interactions matter. St. John’s wort can interact with many prescription medications.

“Natural” does not answer safety, purity, interaction, or efficacy.

For vaginal dryness or painful sex

Regular vaginal moisturizers and lubricants during sexual activity are genuinely useful first-line measures for milder symptoms and require no prescription. Persistent or more severe symptoms deserve a clinician who can distinguish GSM from infection, dermatologic disease, pelvic-floor dysfunction, and other causes.

---

When online HRT care isn’t the right starting point

Answer capsule: Online care is not the right first step when a symptom needs examination, urgent evaluation, imaging, or close coordination with an existing specialist. Bleeding after menopause, new pelvic pain, severe or sudden symptoms, and complex cancer or clotting histories should not be reduced to a telehealth checkout decision.

We would rather lose you here than route you wrong.

Book an in-person evaluation first when any of these apply

• Any vaginal bleeding after menopause. It deserves prompt evaluation. Do not let a product page explain it away.
• New or unexplained pelvic pain, a pelvic mass sensation, or new bleeding after sex.
• Severe or sudden symptoms, including symptoms that could represent an emergency.
• A personal history of breast, uterine, ovarian, or another hormone-sensitive cancer when treatment requires coordination with oncology or a clinician who knows the full history.
• A history of blood clots, stroke, significant cardiovascular disease, or a known clotting disorder that needs individualized risk assessment.
• A symptom pattern that does not fit menopause or has not been evaluated.
• A need for pelvic examination, cervical screening, breast evaluation, imaging, biopsy, or procedure.

None of this automatically means hormone therapy is permanently off the table. It means the first conversation belongs with a clinician who can examine you, access the relevant records, and coordinate care—not only with an intake form.

---

How did The HRT Index compare these providers?

Answer capsule: The HRT Index Verification Standard checks every published price, separates FDA-approved from compounded medication, verifies state and insurance language, records cancellation and billing clocks, and rechecks on a fixed schedule. The Standard uses five pillars and does not produce a numeric provider score.

We evaluate providers on exactly five pillars, always in this order:

1. Clinical legitimacy — who prescribes, under what licensure and oversight.
2. Care quality — visit format, follow-up, messaging, labs, continuity.
3. Medication fit — product, route, pharmacy, FDA-approved or compounded.
4. Price transparency — what is published, omitted, charged later, or confirmed only at checkout.
5. Access — state, age, insurance, federal-program, and clinical exclusions.

We do not assign invented scores and do not rank by commission.

What we actually verified on August 21, 2026

• 1st Optimal’s women’s plan prices, FAQ, Terms, membership-duration language, public menopause route list, and named affiliated pharmacy.
• Midi’s current self-pay prices, commercial-PPO language, Medicare self-pay rule, Medicaid/Medi-Cal exclusion, and 25-jurisdiction compounded-testosterone list.
• Alloy’s current product catalog, $49 consultation fee, and multi-month billing for the estradiol patch and vaginal cream.
• Winona’s current patch and progesterone prices, 28-day processing language, age gate, asynchronous-care format, and compounded-versus-FDA-approved product labeling.
• Sesame’s current $59 standard women’s health price, $49 eligible Costco-member price, cash-pay insurance rule, cancellation terms, controlled-substance restriction, and federal-program beneficiary certification.
• Elektra’s cash prices, Medicare/Medicaid positioning, 16-state clinical footprint, FDA-approved-only medication statement, and New York testosterone availability.
• MyMenopauseRx’s $150 self-pay visit, seven named commercial plan families, Medicare/Medicaid/HMO exclusion, local-pharmacy model, and testosterone restrictions.
• Gennev’s $250 initial and $199 physician follow-up prices.
• Stella’s $200 initial and $90 follow-up prices, superbill statement, in-network marketing language, and conflicting Terms language.
• Wisp’s $99 consult package, three-month access window, local-pharmacy medication, and current state access statement.
• FDA guidance on compounded drugs and NDC numbers; DEA scheduling of testosterone; ACOG’s compounded-hormone consensus; The Menopause Society’s hormone-therapy and testosterone guidance; current labels and safety communications for nonhormonal vasomotor drugs.

What remains a checkout, benefits, or clinician question

• Which 1st Optimal commitment statement governs an individual account.
• The exact tests included in each 1st Optimal plan and the price of any separately billed prescription.
• 1st Optimal’s complete current state footprint and product-level FDA-approved-versus-compounded map.
• Any insured patient’s exact copay, deductible, coinsurance, lab coverage, and pharmacy cost.
• The exact clinician-selected product, dose, quantity, and follow-up cadence at every provider.
• Whether a provider’s state list or plan network changes after this verification date.
• Whether a patient qualifies medically for any listed treatment.

We did not enroll, receive care, buy medication, submit an insurance claim, or test cancellation at any provider on this page. If we had, we would say so. Published information can change between verification and checkout, so confirm material facts in writing before payment.

---

Which 1st Optimal alternative should you choose?

Answer capsule: Start with the problem you need to solve. Commercial PPO readers generally compare Midi first; Medicare or Medicaid readers check Elektra; cash-pay readers on one medication compare Alloy; bundled patch-and-progesterone readers check Winona; video-and-lab readers compare Sesame; and broad functional-medicine readers may be better staying after receiving an itemized estimate.

If this is you	Start here	Do they pay us?
Commercial PPO, want the visit billed	Midi Health	No under the current sitewide disclosure
Medicare or Medicaid	Elektra Health, if your state and plan are supported	No
Cash-pay, one medication, want visible pricing	Alloy	No
Want an FDA-approved patch and progesterone shipped together	Winona, if age and state eligible	Yes, potentially
Want live video, current program labs, and local pharmacy	Sesame	Yes, potentially
Want a $150 self-pay visit or commercial insurance	MyMenopauseRx	No
Want live specialist care without a membership	Gennev or Stella	No
Want a $99 three-month consult package	Wisp	Yes, potentially
Want existing-network coordination and local examination	Your own clinician	No
Want broad functional labs, coaching, monitoring, and can afford cash-pay	Possibly stay with 1st Optimal after a written 120-day estimate	No
Main symptom is vaginal dryness or painful sex	Choose the local-treatment route first, then the provider	Varies
Bleeding after menopause, new pelvic pain, or severe symptoms	In-person clinician first	No

Choosing an alternative is not automatically an upgrade. The right reason to switch is that a different care model fits your symptom, coverage, state, risk history, and budget better—not that another homepage shows a smaller monthly number.

We have now published multiple options that earn us nothing, an honest case for staying with 1st Optimal, and the reason our top recommendation may be wrong for you. That is the page we would want someone to write for our own mother.

Still not sure which HRT program is right for you? Use Find My HRT Path to get your personalized starting-point plan.

---

Frequently asked questions

Is 1st Optimal legitimate?

1st Optimal operates a telehealth service, publishes named plans, maintains a patient portal, identifies an affiliated 503A pharmacy in its Terms, and provides contact information and policies. The central decision on this page is not whether the company exists; it is whether its cash-pay functional-medicine membership, product category, commitment, and total cost fit your needs.

How much does 1st Optimal cost per month?

Its current women’s plans list Perimenopause Care at $129 a month and Menopause Care at $239 a month. The plan pages include ongoing blood-work monitoring and coaching language. Exact included testing and separately priced treatment should be itemized before payment.

Is 1st Optimal month-to-month or a 120-day commitment?

Its FAQ says month-to-month with no long-term contract. Its Terms say a minimum of 120 days and require a membership-change request after that initial period and at least seven days before the next billing cycle. Its membership page connects duration to the prescribed protocol. Ask which document and exit date apply to your account in writing.

What is the four-month cost of 1st Optimal?

Four $129 charges equal $516 and four $239 charges equal $956. A fifth charge would bring the figures to $645 and $1,195. These are editorial billing scenarios, not guaranteed all-in treatment totals, because medication, nonincluded testing, and actual cancellation timing remain variable.

Does 1st Optimal take insurance?

Its public model is cash-pay and it accepts HSA or FSA funds. HSA/FSA acceptance is not direct insurance billing. Ask whether it will provide a superbill for your exact service, which codes and clinical entity appear on it, and whether your plan recognizes them.

Does 1st Optimal prescribe FDA-approved or compounded hormones?

The public menopause page does not map every route to a specific finished product. Its Terms name an affiliated 503A compounding pharmacy, and its public pages discuss compounded routes. Ask for the exact product, manufacturer or labeler, pharmacy, and whether the finished prescription is FDA-approved or compounded before paying.

Does an NDC number prove that a drug is FDA-approved?

No. FDA states that assignment of an NDC number does not denote approval. Verify the exact manufactured product through Drugs@FDA or current FDA-approved labeling. An NDC may help identify a package, but it is not an approval certificate.

Which 1st Optimal alternative bills commercial insurance?

Midi, MyMenopauseRx, Gennev, Stella, and Elektra publish insurance or reimbursement pathways. Networks differ by state and exact plan. A provider being associated with a carrier does not confirm your employer group, deductible, referral rule, or pharmacy benefit.

Which alternative accepts Medicare or Medicaid?

Elektra is the only provider in this ten-option roster whose official site explicitly publishes participation with both Medicare and Medicaid. Coverage remains plan- and state-specific. Midi is out of network with Medicare and does not treat Medicaid or Medi-Cal patients.

What is the cheapest 1st Optimal alternative?

There is no honest single answer without specifying what is included. Wisp has a $99 three-month care package but medication is extra. MyMenopauseRx is $150 per self-pay visit. Sesame publishes $59 a month, or $49 for eligible Costco members, with medication separate. Alloy can be low cost for one medication but commonly charges a multi-month supply at once.

Can I get vaginal estrogen from 1st Optimal?

1st Optimal’s GSM article names low-dose vaginal estrogen as a treatment category, but its public menopause program page does not clearly identify current product availability or price. Ask whether it can prescribe the exact local product you need and whether that finished medication is FDA-approved or compounded.

How do I cancel 1st Optimal?

Its Terms direct members to a membership-change request and say requests must be made after the initial 120 days and at least seven days before the next billing cycle. Its FAQ describes month-to-month billing. Confirm the earliest effective date and whether a pharmacy order is already in process before submitting cancellation.

Will a new provider continue my current prescription?

Not automatically. A new clinician may change or decline a compounded formula, pellet plan, dose, or product she cannot independently verify. Export your records, obtain the exact label and formulation, and secure replacement care before cancelling.

Does any online provider prescribe testosterone for women?

Some do, under restricted state and clinical rules. No testosterone product is FDA-approved specifically for women, and testosterone is Schedule III. A clinician may use a manufactured product off-label at an appropriate female dose or prescribe a compounded product. 1st Optimal, Midi, and MyMenopauseRx publish pathways; Elektra says some clinicians prescribe to New York residents; Sesame does not permit online controlled-substance prescribing; and Winona says it does not offer testosterone.

Do I need progesterone with estrogen?

If you have an intact uterus and use systemic estrogen, your regimen generally needs endometrial protection—often a progestogen or another approved protective regimen. Low-dose local vaginal estrogen is a separate category. Ask what exact product and route protects the uterine lining and how the clinician will monitor the plan.

Is compounded hormone therapy the same as FDA-approved hormone therapy?

No. A compounded finished drug is not FDA-approved, and FDA does not review it for safety, effectiveness, or quality before marketing. Compounding can meet a patient-specific need, but it should not be described as equivalent to an FDA-approved product. ACOG recommends approved formulations over routine compounded menopausal hormone therapy when approved options exist.

Is Winona cheaper than 1st Optimal?

Winona’s patch plus progesterone capsules total $188 per 28-day processing cycle. Four cycles equal $752; five charges equal $940. 1st Optimal Menopause Care is $239 per calendar-month charge, or $956 for four charges, before any separately priced medication. The products are structured differently, so compare the exact charge dates and what each includes.

What should I do if I still do not know which route I need?

Use The HRT Index’s Find My HRT Path tool to sort your symptom pattern, age, uterus status, route preference, risk history, insurance, and state into the right starting lane—and to flag when online care is not the right first step.

---

Primary-source verification ledger

Commercial facts were checked against the provider pages below on August 21, 2026. Affiliate-status language was aligned to The HRT Index’s live sitewide disclosure on the same date. Medical and regulatory statements were checked against FDA, DEA, ACOG, The Menopause Society, current labeling, and peer-reviewed sources.

1st Optimal

• Women’s plan prices and benefits
• Terms of Service: 120-day minimum, seven-day notice, affiliated pharmacy
• FAQ: membership inclusions and month-to-month language
• Women’s membership duration example
• Menopause program routes

Alternatives

• Midi pricing and insurance
• Midi HRT access and federal-program rules
• Midi women’s testosterone availability and state list
• Alloy product catalog
• Alloy estradiol patch and three-month billing
• Alloy vaginal estradiol cream package price
• Winona FAQ
• Winona treatment catalog
• Winona compounded vaginal estrogen cream
• Sesame women’s health
• Sesame Costco-member rates
• Sesame controlled-substance statement
• Sesame Terms: insurance, cancellation, and federal-program eligibility
• Elektra FAQ and cash prices
• Elektra Medicare and Medicaid statement
• MyMenopauseRx pricing
• MyMenopauseRx FAQ
• Gennev insurance and pricing
• Stella pricing and insurance marketing
• Stella Terms of Service
• Wisp menopause consult

• The HRT Index sitewide affiliate disclosure

Medical and regulatory sources

• FDA: NDC numbers do not denote approval
• FDA: compounded drugs are not FDA-approved
• ACOG Clinical Consensus on compounded menopausal hormone therapy
• The Menopause Society 2022 hormone-therapy position statement
• The Menopause Society testosterone practice resource
• DEA drug scheduling: testosterone is Schedule III
• FDA boxed warning for Veozah liver injury
• Current Lynkuet labeling
• ACOG hormone-therapy patient guidance

---

The HRT Index is an independent decision resource for online menopause and HRT care. This page is editorial research and is not medically reviewed by a clinician. It is educational only and is not medical advice. Prices, networks, state access, medication catalogs, and policies change. Top providers are rechecked monthly and the full roster quarterly under The HRT Index Verification Standard. Last verified August 2026.